My Partner Is HIV Positive and I Am Negative: Can We Have a Baby?

Serodiscordant couples, where one partner is living with HIV and the other is not, can absolutely have a baby together with very low risk of transmitting the virus to either the uninfected partner or the child. Modern antiretroviral therapy has changed the landscape so dramatically that natural conception is now considered a reasonable option for many of these couples, and several assisted reproduction techniques can reduce risk even further. The path you take depends on which partner is HIV-positive, how well the virus is controlled, and what resources are available to you.

Why Viral Suppression Changes Everything

The single most important factor in safely conceiving is whether the HIV-positive partner’s viral load is undetectable. When someone takes antiretroviral therapy consistently and their blood tests show no detectable virus, the risk of passing HIV through sex drops to effectively zero. This finding, confirmed in large studies of both heterosexual and same-sex couples having condomless sex over thousands of couple-years of follow-up, is the basis of the U=U campaign: undetectable equals untransmittable.¹

For couples trying to conceive, this is transformative. Before effective antiretroviral therapy existed, any attempt at pregnancy through unprotected sex carried a meaningful chance of infecting the negative partner. Now, if the positive partner maintains viral suppression, the act of trying to get pregnant does not need to be a high-stakes gamble. Researchers have noted that both sexual and perinatal transmission correlate directly with viral replication, and when viremia is fully suppressed, the transmission risk becomes negligible enough that natural conception is a valid option.²

That said, “effectively zero” is not the same as a mathematical guarantee, and many couples prefer layered protection. The strategies available differ depending on whether it is the male or female partner who is HIV-positive.

When the Male Partner Is HIV-Positive

If you are a woman whose male partner has HIV, you have several options ranging from low-tech to medically assisted.

The most established clinical approach is sperm washing. The technique separates sperm cells from the seminal fluid where HIV particles reside. A systematic review covering nearly 4,000 women and over 11,500 cycles of assisted reproduction using washed sperm found zero cases of HIV transmission to any female partner. Even among a subset of men who did not have full viral suppression at the time of washing, no seroconversions occurred across nearly 3,000 cycles. About 56% of couples achieved a clinical pregnancy with washed sperm, and no cases of mother-to-child transmission were reported among the babies born.³ That track record of safety extends across decades of published data from multiple countries.⁴

Sweden’s national data on 15 years of assisted reproduction with sperm washing and intracytoplasmic sperm injection (where a single washed sperm is injected directly into an egg) confirms this safety record. No post-wash sperm samples tested positive for HIV, no partners seroconverted, and no offspring were infected. Reproductive outcomes were comparable to those seen in couples where the male partner had hepatitis B instead of HIV.⁵

For couples who prefer a simpler route, timed natural intercourse during the woman’s fertile window is increasingly supported when the male partner’s viral load is fully suppressed. This limits the number of unprotected exposures needed to conceive. The HIV-negative partner can also take pre-exposure prophylaxis (PrEP) as an added safety layer during the conception period, even when the positive partner’s virus is already undetectable.⁶ PrEP is particularly useful during the peri-conception window, when condom use is necessarily reduced and any lingering anxiety about transmission can be eased by knowing both partners have pharmacological protection.⁷

When the Female Partner Is HIV-Positive

If you are a man whose female partner has HIV, the conception logistics are somewhat different. The main risk during natural conception flows from the man’s exposure to cervicovaginal secretions and blood, so reducing his contact with the virus matters.

One low-tech option is vaginal self-insemination, sometimes called the “turkey baster” method. The male partner ejaculates into a container, and the semen is drawn into a needleless syringe and inserted into the vagina. This avoids sexual contact entirely, eliminating the man’s risk of exposure. Qualitative research has found that HIV-negative men and their HIV-positive female partners generally view self-insemination favorably, and some men actually prefer it over taking PrEP themselves.⁸

Timed natural intercourse is also an option here if the woman’s viral load is fully suppressed. The same U=U principle applies: with consistent antiretroviral therapy and an undetectable viral load, the risk of transmitting HIV to a sexual partner is effectively zero. The male partner can add PrEP during the conception period for additional reassurance. The key is that the woman’s treatment is stable and her viral load has been consistently undetectable, not just checked once.

How HIV and Antiretrovirals Can Affect Fertility

Couples should know that both HIV itself and the medications used to treat it can complicate the fertility picture. This doesn’t mean you can’t get pregnant, but it may mean the process takes longer or benefits from specialist guidance.

For men, HIV infection tends to lower semen quality. A study of 770 HIV-positive men found that their semen parameters were significantly lower across the board compared to reference values from the general population, with viral load and age being the strongest negative predictors of sperm motility and morphology.⁹ On top of that, antiretroviral therapy itself may increase sperm DNA fragmentation. One study found that roughly two-thirds of men on treatment had elevated DNA fragmentation levels, compared to about a third of HIV-positive men not yet on treatment.¹⁰ High DNA fragmentation doesn’t necessarily prevent pregnancy, but it can reduce success rates with natural conception and some forms of assisted reproduction.

For women, HIV infection has been linked to ovarian dysfunction, irregular periods, and prolonged gaps between menstrual cycles. Markers of more advanced disease, such as a low CD4 count or detectable viremia, correlate with lower ovarian reserve. And some of the backbone medications used during the preconception period have shown concerning effects on egg quality and mitochondrial function in laboratory and animal studies, though translating those findings directly to clinical outcomes in humans requires caution.¹¹

None of this means fertility is off the table. Many HIV-positive individuals conceive without difficulty. But if you’ve been trying for several months without success, the virus and its treatment may be contributing factors worth discussing with a reproductive specialist.

Pre-Conception Planning and Screening

Before trying to conceive, both partners should be screened for sexually transmitted infections. Even though antiretroviral therapy and PrEP eliminate the HIV transmission risk, untreated STIs can cause pregnancy complications, and treating them beforehand is straightforward. U.S. perinatal guidelines recommend rescreening during the conception period as well, based on individual risk and how long you’ve been trying.¹²

Pre-conception is also the time to confirm that the positive partner’s viral load is genuinely suppressed, ideally undetectable for at least several months. If there have been gaps in medication adherence or recent viral “blips” (brief, low-level spikes in detectable virus), your medical team will want to stabilize the viral load before proceeding. The goal is to enter conception, pregnancy, and delivery with the virus as controlled as possible.

Protecting the Baby During Pregnancy and Delivery

When the mother is HIV-positive, the pregnancy itself requires careful management to prevent transmission to the baby. The good news is that consistent antiretroviral therapy during pregnancy, combined with modern obstetric care, has driven perinatal transmission rates in high-income countries to well below 1%.

U.S. guidelines recommend that pregnant women living with HIV maintain an undetectable viral load, specifically below 50 copies per milliliter, for at least three months before delivery.¹³ When that target is met, the delivery method generally follows normal obstetric indications. A vaginal delivery is safe.

The calculus shifts when the viral load is higher. U.S. and U.K. guidelines both recommend considering a planned cesarean section when the mother’s viral load exceeds 1,000 copies per milliliter near the time of delivery, because the baby’s exposure to maternal blood and secretions during a vaginal birth carries greater risk at higher viral levels. When the viral load falls between 50 and 999 copies, the decision becomes more individualized, taking into account the trajectory of the viral load, how long the mother has been on treatment, and other obstetric factors.¹⁴

A network meta-analysis of randomized trials found that certain antiretroviral regimens taken during pregnancy substantially reduce mother-to-child transmission. The review also found that none of the regimens studied were statistically associated with increases in neonatal mortality, stillbirth, congenital defects, preterm birth, or low birth weight compared to placebo.¹⁵

What Happens After the Baby Is Born

All newborns with exposure to HIV during pregnancy or delivery receive antiretroviral medication shortly after birth, ideally within six hours. The intensity of this prophylaxis depends on the mother’s viral control. If her viral load was consistently below 50 copies throughout the second half of pregnancy and at delivery, the baby typically receives a single drug for two weeks. If there was detectable virus in the four weeks before delivery, guidelines call for a three-drug regimen lasting two to six weeks, essentially treating the baby as though early infection is possible and needs to be stamped out.¹⁶

Infant feeding is another area where recommendations have evolved substantially. For years, U.S. guidelines categorically advised against breastfeeding for HIV-positive mothers, even if their virus was well controlled. That changed in 2023. The updated guidelines now recommend shared decision-making: if the mother is on consistent antiretroviral therapy with sustained viral suppression, she can be counseled on formula feeding, banked donor milk, or breastfeeding, and supported without judgment in whatever she chooses.¹⁷ The shift reflects growing evidence that transmission through breast milk is very low when viral suppression is maintained, alongside recognition that formula-only policies could conflict with cultural norms and create equity concerns.

Health of HIV-Exposed but Uninfected Children

The vast majority of babies born to HIV-positive parents through these strategies are HIV-negative. Globally, an estimated 16 million children fall into the category of “HIV-exposed but uninfected,” meaning they were exposed to the virus in utero or during infancy but did not acquire it.¹⁸

These children do well overall, but research suggests they may face some subtle health differences compared to children who were never exposed. Reviews have flagged slightly higher rates of immune changes, growth delays, and possible neurocognitive differences in this population.¹⁹ A systematic review focusing specifically on growth found that exposed-but-uninfected children had more growth faltering than unexposed peers, with differences visible from birth and persisting through the first two years of life. These differences were present even in the era of effective antiretroviral therapy.²⁰

It is worth keeping this in context. The differences are statistical trends across large populations, not deterministic predictions for any individual child. Many of the studies come from sub-Saharan Africa, where poverty, malnutrition, and co-infections cloud the picture. Researchers are actively working to understand which factors drive these disparities and whether early interventions, potentially starting before birth, can close the gap. For a well-resourced couple in a high-income country working closely with their medical team, these population-level findings are useful to know about but should not be a source of alarm.

Getting Access to Reproductive Services

One of the frustrating realities for serodiscordant couples is that finding a fertility clinic willing to help can be harder than it should be. A survey of assisted reproduction clinics across 15 U.S. states found that when a patient called and disclosed their HIV status, only about 40% of clinics said they could offer services. When a physician called the same clinics on behalf of a patient, that number jumped to 63%. Roughly half of the clinics that turned away patient callers did refer them to another facility that could help, but a third of clinics would not assist at all regardless of the reason for the visit.²¹

The gap between physician-initiated and patient-initiated calls hints at stigma playing a role in how clinics respond. And the access problem is far more acute in lower-income countries. In Kenya, for example, healthcare providers and couples have reported that antiretroviral-based prevention strategies are acceptable and accessible, but medically assisted reproduction techniques like sperm washing and IVF remain cost-prohibitive for most people.²²

If your first call to a clinic is met with hesitation or refusal, persistence pays off. Ask for a referral. Have your HIV specialist or primary care provider make the call. And know that the science is firmly on your side: the evidence shows these procedures are safe, and the reluctance of some clinics reflects outdated policies more than current medical reality.

Stigma and Mental Health During the Process

The emotional weight of planning a pregnancy in a serodiscordant relationship deserves acknowledgment. Even when the science is clear, the experience of navigating healthcare systems, managing disclosure, and contending with others’ misconceptions about HIV can take a toll. Research on serodiscordant couples in Kenya found that HIV-related stigma perceived by either partner was detrimental not only to their own mental health but also to their partner’s, increasing symptoms of depression and anxiety even after accounting for overall relationship quality.²³

Stigma operates at multiple levels. Families and social networks can be sources of discrimination, and broader community attitudes about HIV often lag far behind the medical science.²⁴ Some couples report that well-meaning relatives question their decision to have children at all, or that friends treat the pregnancy as inherently risky despite reassurance from doctors. If you encounter this, connecting with peer support groups for serodiscordant couples or seeking counseling from providers experienced in HIV care can help you build a buffer against external pressure. The decision to have a child is yours and your partner’s, and the evidence supports your ability to do so safely.